S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors

被引:2
|
作者
Mandarino, Angelo [1 ]
Thiyagarajan, Swetha [1 ]
Martins, Allana C. F. [1 ]
da Silva Gomes, Roberto [1 ]
Vetter, Stefan W. [1 ]
Leclerc, Estelle [1 ]
机构
[1] North Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA
关键词
S100; protein; HMGB1; pancreatic cancer; GLYCATION END-PRODUCTS; CALCIUM-BINDING PROTEIN; CELL-PROLIFERATION; EXPRESSION; RAGE; PROMOTES; INVASION; RECEPTOR; GROWTH; MIGRATION;
D O I
10.3390/biom13081175
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pancreatic cancer remains a disease that is very difficult to treat. S100 proteins are small calcium binding proteins with diverse intra- and extracellular functions that modulate different aspects of tumorigenesis, including tumor growth and metastasis. High mobility group box 1 (HMGB1) protein is a multifaceted protein that also actively influences the development and progression of tumors. In this study, we investigate the possible correlations, at the transcript level, between S100s and HMGB1 in pancreatic cancer. For this purpose, we calculated Pearson's correlations between the transcript levels of 13 cancer-related S100 genes and HMGB1 in a cDNA array containing 19 pancreatic cancer tumor samples, and in 8 human pancreatic cancer cell lines. Statistically significant positive correlations were found in 5.5% (5 out of 91) and 37.4% (34 of 91) of the possible S100/S100 or S100/HMGB1 pairs in cells and tumors, respectively. Our data suggest that many S100 proteins crosstalk in pancreatic tumors either with other members of the S100 family, or with HMGB1. These newly observed interdependencies may be used to further the characterization of pancreatic tumors based on S100 and HMGB1 transcription profiles.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] HMGB1 as a therapeutic target for sepsis: it's all in the timing!
    Gentile, Lori F.
    Moldawer, Lyle L.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (03) : 243 - 245
  • [22] Establishment of in vitro binding assay of HMGB1 and S100A12 to RAGE:effect of heparin on the binding
    Liu, Rui
    Mori, Shuji
    Wake, Hidenori
    Zhang, Jiyong
    Liu, Keyue
    Izushi, Yasuhisa
    Takahashi, Hideo
    Nishibori, Masahiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 165P - 165P
  • [23] Autoantibodies targeting HMGB1 and the main C1s generated HMGB1 fragment in systemic lupus erythematosus: Prevalence and characterization
    Vigne, Jeanne
    Lorvellec, Marie
    Clavarino, Giovanna
    Defendi, Federica
    Sarrot-Reynauld, Francoise
    Jourde-Chiche, Noemie
    Thielens, Nicole
    Gaboriaud, Christine
    Rossi, Veronique
    Dumestre-Perard, Chantal
    IMMUNOBIOLOGY, 2023, 228 (05) : 50 - 50
  • [24] HMGB1 is a Potential and Challenging Therapeutic Target for Parkinson’s Disease
    Yu Tian
    Rong Chen
    Zhaoliang Su
    Cellular and Molecular Neurobiology, 2023, 43 : 47 - 58
  • [25] Exosomal HMGB1 Promoted Cancer Malignancy
    Wang, Jiaan-Der
    Wang, Ya-Yu
    Lin, Shih-Yi
    Chang, Cheng-Yi
    Li, Jian-Ri
    Huang, Shi-Wei
    Chen, Wen-Ying
    Liao, Su-Lan
    Chen, Chun-Jung
    CANCERS, 2021, 13 (04) : 1 - 16
  • [26] HMGB1 is a Potential and Challenging Therapeutic Target for Parkinson's Disease
    Tian, Yu
    Chen, Rong
    Su, Zhaoliang
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2023, 43 (01) : 47 - 58
  • [27] HMGB1 as the therapeutic target in gastric cancer
    Takaki, Wataru
    Konishi, Hirotaka
    Arita, Tomohiro
    Kosuga, Toshiyuki
    Shiozaki, Atsushi
    Nakanishi, Masayoshi
    Kubota, Takeshi
    Fujiwara, Hitoshi
    Okamoto, Kazuma
    Otsuji, Eigo
    CANCER SCIENCE, 2021, 112 : 429 - 429
  • [28] Role of Serum HMGB1 in Prostate Cancer
    Solakhan, Mehmet
    Cicek, Hulya
    Benlier, Necla
    Yildirim, Zeliha
    Sever, Ozlem Nuray
    Orhan, Nun
    Yildirim, Mustafa
    EUROPEAN JOURNAL OF THERAPEUTICS, 2020, 26 (02): : 108 - 112
  • [29] The Role of HMGB1 in Radioresistance of Bladder Cancer
    Shrivastava, Sanhita
    Mansure, Jose Joao
    Almajed, Wael
    Cury, Fabio
    Ferbeyre, Gerardo
    Popovic, Marija
    Seuntjens, Jan
    Kassouf, Wassim
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (03) : 471 - 479
  • [30] The role of HMGB1's critical cysteines are explored in human monocytes
    Bauer, Eileen
    Deng, Peng
    Gollapudi, Venkata Sashi
    Shapiro, Richard
    Li, Tunliang
    Billiar, Timothy
    JOURNAL OF IMMUNOLOGY, 2015, 194